Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience-Reference-Cited by-同舟云学术

Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience

Published:2022-07 Issue:7 Volume:15 Page:100664
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Abuzakouk Mohamed,Ghorab Omar^ORCID,Al-Hameli Hamad,Salvo Fulvio,Grandon Deepa,Maurer Marcus^ORCID

Funder

Charité – Universitätsmedizin Berlin

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference13 articles.

1. Prospective analysis in patients with HAE under prophylaxis with lanadelumab: a real-life experience;Hahn;J Drugs Dermatol JDD,2020

2. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group;Cicardi;Allergy,2014

3. Hereditary angioedema type II: first presentation in adulthood with recurrent severe abdominal pain;Authors;Case Reports Immunol,2018

4. The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update;Authors;World Allergy Organ J,2022

5. Critical appraisal of androgen use in hereditary angioedema: a systematic review;Riedl;Ann Allergy Asthma Immunol,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center;Frontiers in Immunology;2024-05-10

2. Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

3. Safety Aspects and Rational Use of Lanadelumab Injections in the Treatment of Hereditary Angioedema (HAE): Clinical Insights;Drug, Healthcare and Patient Safety;2022-12